Altimmune Inc banner

Altimmune Inc
F:3G0

Watchlist Manager
Altimmune Inc Logo
Altimmune Inc
F:3G0
Watchlist
Price: 2.45 EUR 1.66%
Market Cap: €173.7m

Wall St Price Targets

3G0 Price Targets Summary
Altimmune Inc

There are no price targets for 3G0.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Altimmune Inc Competitors:
Price Targets
VYNE
Vyne Therapeutics Inc
200% Upside
MTLS
Materialise NV
70% Upside
1981
Cathay Media and Education Group Inc
40% Upside

Revenue
Forecast

-37% / Year
Past Growth
276% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
-37% / Year
Past Growth
276% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been -37%. The projected CAGR for the next 8 years is 276%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-88%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 3G0's stock price target?
Not Available

3G0 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Altimmune Inc?
Projected CAGR
276%

Over the last 14 years, the compound annual growth rate for Revenue has been -37%. The projected CAGR for the next 8 years is 276%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett